^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

PPM1D mutation

i
Other names: PPM1D, Protein Phosphatase Mg2+/Mn2+ Dependent 1D, Protein Phosphatase 1D Magnesium-Dependent Delta Isoform, Wild-Type P53-Induced Phosphatase 1, Protein Phosphatase 1D, WIP1, Protein Phosphatase Magnesium-Dependent 1 Delta, Protein Phosphatase Mg2+/Mn2+ Dependent 1D, Protein Phosphatase 2C Delta Isoform, Protein Phosphatase 2C Delta Isoform, Protein Phosphatase 2C Isoform Delta, P53-Induced Protein Phosphatase 1, Protein Phosphatase Wip1, PP2C-DELTA, PP2C-Delta, IDDGIP, JDVS 3
Entrez ID:
Phase 2
University Health Network, Toronto
Active, not recruiting
Last update posted :
01/17/2024
Initiation :
07/19/2016
Primary completion :
12/31/2025
Completion :
12/31/2025
BRCA1 • BRCA2 • PALB2 • RAD51B • BRIP1 • RAD51C • PARP1 • RAD51D • BARD1 • PPM1D • FANCM
|
BRCA2 mutation • BRCA1 mutation • PALB2 mutation • BRIP1 mutation • RAD51C mutation • RAD51D mutation • RAD51B mutation • BARD1 mutation • PPM1D mutation • FANCM mutation • RAD51 mutation
|
Lynparza (olaparib)
Phase 1
Dana-Farber Cancer Institute
Completed
Last update posted :
08/11/2023
Initiation :
11/01/2018
Primary completion :
07/17/2023
Completion :
07/17/2023
TP53 • MDM2 • TET2 • SMARCB1 • PPM1D
|
TP53 wild-type • MDM2 amplification • TET2 mutation • SMARCA4 mutation • PPM1D mutation
|
cytarabine • ALRN-6924